Leenaars et al., 1994 - Google Patents
Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbitsLeenaars et al., 1994
- Document ID
- 4690048751488891056
- Author
- Leenaars P
- Hendriksen C
- Angulo A
- Koedam M
- Claassen E
- Publication year
- Publication venue
- Veterinary immunology and immunopathology
External Links
Snippet
In three experiments we evaluated several types of adjuvants as an alternative to Freund's adjuvant (FA). In the first experiment three adjuvant preparations (a water-in-oil emulsion (Specol), a combination preparation of monophosphoryl lipid A+ trehalose dimycolate+ cell …
- 239000002671 adjuvant 0 title abstract description 65
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Leenaars et al. | Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits | |
| JP2690620B2 (en) | Improvements in or related to vaccines | |
| Sher et al. | Schistosome vaccines: current progress and future prospects | |
| JP7072921B2 (en) | Group A streptococcal vaccine | |
| EA007533B1 (en) | A METHOD FOR DECREASING REGULATION OF THE PRECIOUS PROTECTOR OF AMYLOID | |
| WO1989006974A2 (en) | T-cell epitope as carriers molecule for conjugate vaccines | |
| MISHIMA et al. | Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1 | |
| Picchio et al. | Vaccine potential of antigen cocktails composed of recombinant Toxoplasma gondii TgPI-1, ROP2 and GRA4 proteins against chronic toxoplasmosis in C3H mice | |
| CN102488898B (en) | Carious tooth vaccine and preparation method | |
| CN109069424A (en) | Liposome bacterin | |
| JPH04502610A (en) | Synthetic peptides derived from streptococcal M protein and vaccines prepared from the peptides | |
| PT680765E (en) | NON-TYPICAL STRAIN VACCINE OF HAEMOPHILUS INFLUENZAE. | |
| CA1331445C (en) | Vaccine against e. coli septicaemia in poultry | |
| Takahashi et al. | Intranasal immunization of mice with recombinant protein antigen of serotype cStreptococcus mutans and cholera toxin B subunit | |
| Tappeh et al. | A novel adjuvant, mixture of Alum and naltrexone, elicits humoral immune responses for excreted/secreted antigens of Toxoplasma gondii tachyzoites vaccine in Balb/c murine model | |
| Arnon | Peptides as immunogens: prospects for synthetic vaccines | |
| Xu et al. | Immunogenicity and protective efficacy of a targeted fusion DNA construct against dental caries | |
| JPH07505878A (en) | Synthetic polypeptide derived from HIV envelope glycoprotein | |
| US7323175B2 (en) | Immunogenicity of glucan binding protein | |
| Stewart-Tull | Immunopotentiating conjugates | |
| Olive et al. | Towards the development of a broadly protective group A streptococcal vaccine based on the lipid-core peptide system | |
| Stewart | Vaccination against footrot and foot abscess | |
| Moyle et al. | Development of lipid-core-peptide (LCP) based vaccines for the prevention of group A streptococcal (GAS) infection | |
| US7163682B2 (en) | Glucan binding protein and glucosyltransferase immunogens | |
| Leenaars | Adjuvants in Laboratory Animals: evaluation of immunostimulating properties and side effects of Freund's complete adjuvant and alternative adjuvants in immunization procedures |